Fevertree Drinks PLC Director/PDMR Shareholding (7182S)

TIDMFEVR

RNS Number : 7182S

Fevertree Drinks PLC

18 July 2022

18 July 2022

Fevertree Drinks plc

("Fever-Tree" or the "Company")

Director/PDMR Shareholding

Fever-Tree, the world's leading supplier of premium carbonated mixers, announces that on 15 July 2022, Jeff Popkin, a Non-Executive Director of the Company, bought, in aggregate, 15,208 ordinary shares in the Company at a price of USD 10.45 per ordinary share via the US OTC Markets.

Ends

For further information:

Investor queries

Ann Hyams, Director of Investor Relations I [e-mail] I [phone]

Media queries

Oliver Winters, Director of Communications I [e-mail] I [phone]

Nominated Advisor and Joint Broker - Numis Securities

Stuart Dickson I Hugo Rubinstein I [phone]

Joint Broker - Investec Bank plc

David Flin I Alex Wright I [phone]

Financial PR advisers - Finsbury

Faeth Birch [phone]; Anjali Unnikrishnan [phone]; Carolina Neri [phone]

 
      Details of the person discharging managerial responsibilities/person 
  1    closely associated 
 a)   Name                             Jeff Popkin 
     -------------------------------  ----------------------------------------- 
      Reason for the notification 
  2 
     -------------------------------------------------------------------------- 
 a)   Position/status                  Non-Executive Director 
     -------------------------------  ----------------------------------------- 
 b)   Initial notification/Amendment   Initial Notification 
     -------------------------------  ----------------------------------------- 
 3    Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
     -------------------------------------------------------------------------- 
 a)   Name                             Fevertree Drinks plc 
     -------------------------------  ----------------------------------------- 
 b)   LEI                              2138007AJRLHRVQZLD07 
     -------------------------------  ----------------------------------------- 
 4    Details of the transaction(s): section to be repeated for 
       (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transactions 
       have been conducted 
     -------------------------------------------------------------------------- 
 a)   Description of the                 Fever-Tree equity trading OTC as FQVTF 
       financial instrument, 
       type of instrument 
       Identification code                 GB00BRJ9BJ26 
     -------------------------------  ----------------------------------------- 
 b)   Nature of the transaction        Acquisition of FQVTF equity via OTC 
     -------------------------------  ----------------------------------------- 
 c)   Price(s) and volume(s)                 Price (USD)   Volume 
                                         1.   $10.45        15,208 
                                             ------------  ------- 
     -------------------------------  ----------------------------------------- 
 d)   Aggregated information           As above 
     -------------------------------  ----------------------------------------- 
 e)   Date of the transaction          15 July 2022 
     -------------------------------  ----------------------------------------- 
 f)   Place of the transaction         US OTC Market 
     -------------------------------  ----------------------------------------- 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHBRGDRIDBDGDU

(END) Dow Jones Newswires

July 18, 2022 02:00 ET (06:00 GMT)